Company: Oxford Nanopore Technologies
Location:
Posted: April 20th, 2026
Corporate Business Development Director – Human Genetics
Oxford Nanopore Technologies
Oxford (Hybrid Working)
Monthly international travel required
Oxford Nanopore Technologies is a leading life sciences company headquartered in Oxford, UK, focused on the development and commercialisation of nanopore sequencing technologies. Our platform enables real‑time, accessible, and scalable analysis of DNA and RNA, supporting applications across research, clinical, and industrial settings. We are driven by a mission to make genomic analysis widely available and impactful for human health and beyond.
We are seeking an experienced Corporate Business Development Director to lead partnership activities within the Human Genetics segment. This role sits within the Business Development team, which is focused on building a strong ecosystem of strategic partnerships to accelerate adoption of nanopore sequencing and generate long‑term revenue growth. You will develop partnerships with organisations aiming to commercialise applications of nanopore sequencing across prioritised clinical and industrial markets.
This role is well suited to someone who thrives in a collaborative, cross‑functional environment and is motivated to build impactful partnerships that advance genomic technologies in human health.
Please note that no terminology in this advert is intended to discriminate on the grounds of a person’s gender, marital status, race, religion, colour, age, disability or sexual orientation. Every candidate will be assessed only in accordance with their merits, qualifications and abilities to perform the duties of the job.
Oxford Nanopore Technologies: Our goal is to bring the widest benefits to society through enabling the analysis of anything, by anyone, anywhere. The company has developed a new generation of nanopore‑based sensing technology for faster, information‑rich, accessible and affordable molecular analysis. The first application is DNA/RNA sequencing, and the technology is in development for the analysis of other types of molecules including proteins. The technology is used to understand and characterise the biology of humans and diseases such as cancer, plants, animals, bacteria, viruses, and whole environments. With a thriving culture of ambition and strong innovation goals, Oxford Nanopore is a UK‑headquartered company with global operations and customers in more than 125 countries.
#J-18808-Ljbffr